WATCH NOW: Europe's New IVDR 2017/746
Within the next few years, the regulatory landscape will change dramatically for IVD companies selling in Europe. The current In Vitro Diagnostic Devices Directive (98/79/EC), which dates from 1998, has been thrown out the window and will be replaced by the IVDR 2017/746.
What has changed? A lot. The IVDR will be an entirely new classification scheme for IVDS; it places far more emphasis on clinical data and risk management, and expands conformity assessment requirements to 80% of IVD companies. Those are big changes.
TOPICS COVERED
- Framework and overview of IVDR
- IVD classification scheme
- Companion diagnostics
- Conformity assessment and Notified Body involvement
- Emphasis on traceability, vigilance and PMS
- Clinical evidence requirements
- Responsibilities of importers and distributors
Recorded November 2016
ABOUT THE PRESENTER
Dr. Oliver Eikenberg (RAC) is a Senior Regulatory Consultant for Emergo based in Germany. He is an expert in In Vitro Diagnostic devices and previously held QA/RA positions with SYSMEX Inostics, IBL International, Human Biochemica and Diagnostica, ABETA and The Genetics Company. He holds a Ph.D. in Chemistry and Biochemistry from the Technical University of Munich.
We recommend:
Understanding Europe's New In Vitro Diagnostic Medical Devices Regulation
The European Commission's new In Vitro Diagnostic Regulation (IVDR) will address several weaknesses of the IVDD and bring significant regulatory changes for IVD manufacturers selling in Europe. Application is predicted for 2022, but proactive IVD companies are beginning to plan their implementation strategy now. In this white paper, Emergo takes an in-depth look at the IVDR and answers your biggest questions about Europe's changing regulatory landscape. Download now.
有任何问题？向我们的专家获取相关信息
联系我们相关
-
美国FDA eSTAR电子递交模板与资源要求解析
自2018年起，美国食品和药物管理局（U.S. Food and Drug Administration，FDA）开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年，为推进以电子格式提供510(k)递交文件的过渡，美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多 -
墨西哥医疗器械注册和COFEPRIS认证合规审批流程
医疗器械和体外诊断（IVD）器械制造商需要在COFEPRIS注册他们的产品，COFEPRIS是墨西哥卫生部（Secretaría de Salud）的一个机构。器械在上市前需要上市前审批，豁免的器械除外。
阅读更多